| Stonerise Bridgeport | |
| 41 Crestview Terrace, Bridgeport, West Virginia 26330 | |
| (304) 842-7101 | |
| Name | Stonerise Bridgeport |
|---|---|
| Location | 41 Crestview Terrace, Bridgeport, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 85.17% |
| Medicare ID (CCN) | 515141 |
| Legal Business Name | Bridgeport Center Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1144569583 |
| Address | 415 Benedum Dr, Bridgeport, WV 26330 |
| Phone Number | 304-842-9887 |
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
| NPI Number | 1164421756 |
| Organization Name | MEADOWVIEW MANOR HEALTH CARE CENTER INC. |
| Address | 41 Crestview Ter, Bridgeport, WV 26330 |
| Phone Number | 304-842-7101 |
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
| NPI Number | 1558614560 |
| Organization Name | ODYSSEY REHABILITATION |
| Address | 41 Crestview Ter, Bridgeport, WV 26330 |
| Phone Number | 304-842-7101 |
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
| NPI Number | 1871232140 |
| Organization Name | CRESTVIEW TERRACE LEASING CO., LLC |
| Doing Business As | STONERISE BRIDGEPORT |
| Address | 41 Crestview Ter, Bridgeport, WV 26330 |
| Phone Number | 304-842-7101 |
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.35 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.88 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.95 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.96 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.81 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.74 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.71 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.73 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.12 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 63.9 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.8 | 82.93 |
News Archive
Sepsis is a major public health problem, contributing to substantial disability, death, and healthcare costs in the United States among both adults and children.
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.
Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
HealthSpring, Inc. today announced its results for the fourth quarter and year ended December 31, 2009.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 6 days ago
United Transitional Care Center Location: 327 Medical Park Drive, Bridgeport, West Virginia 26330 Phone: (681) 342-5174 | |
Stonerise Bridgeport Location: 41 Crestview Terrace, Bridgeport, West Virginia 26330 Phone: (304) 842-7101 | |
Bridgeport Health Care Center Location: 1081 Maplewood Drive, Bridgeport, West Virginia 26330 Phone: (304) 842-4135 |